Target | MW | Column | Phase |
Particle size(um) |
Pore size (Å) |
||||
Reversed Phase |
Proteins Peptides Oligonucleotides Nucleic Acids |
<5,000 | ProteoSil 100-C18 |
C18 |
1.9, 3 5 |
100 |
|||
5,000 - 20,000 | ProteoSil 200-C18 |
C18 |
1.9, 3 5 |
200 |
|||||
5,000 - 20,000 | ProteoSil 200-C8 |
C8 |
1.9, 3 5 |
200 |
|||||
>20,000 | ProteoSil 300-C18 |
C18 |
5 |
300 |
|||||
>20,000 | ProteoSil 300-C8 |
C8 |
5 |
300 |
|||||
Proteins Peptides Monoclonal Antibodies Oligonucleotides Nucleic Acids |
>20,000 | ProteoSil 300-C4 |
C4 |
5 |
300 |
||||
Proteins Monoclonal Antibodies Antibody-Drug Conjugate(ADC) Sub-unit |
>100,000 | MonoSelect RP-mAb |
Phenyl | Monolith | 600 | ||||
HILIC | Proteins / Peptides Monoclonal Antibodies |
- | ProteoSil HILIC |
Amide | 1.9, 3 5 | 100 | |||
SEC + PR |
Liposome, Exosome | - | MonoSelect nPEC | Hydrophilic Polymer |
Monolith |
110 |
|||
SEC |
Proteins Peptides Monoclonal Antibodies Oligonucleotides/ Nucleic Acids |
5,000 ‐ 600,000 | ProteoSil 300-SEC |
DIOL |
5 |
300 |
|||
<5,000 | ProteoSil 100-SEC |
DIOL | 5 | 100 |